{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:39:16Z","timestamp":1790775556289,"version":"4.1.0"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,13]]},"DOI":"10.18632\/oncotarget.10699","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T11:09:31Z","timestamp":1468926571000},"page":"59482-59502","source":"Crossref","is-referenced-by-count":25,"title":["Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in <i>ApcMin\/+<\/i> mice"],"prefix":"10.18632","volume":"7","author":[{"given":"Aditi A.","family":"Narsale","sequence":"first","affiliation":[{"name":"Department of Exercise Science, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Puppa","sequence":"additional","affiliation":[{"name":"Department of Exercise Science, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"Hardee","sequence":"additional","affiliation":[{"name":"Department of Exercise Science, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon N.","family":"VanderVeen","sequence":"additional","affiliation":[{"name":"Department of Exercise Science, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reilly T.","family":"Enos","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Angela","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Carson","sequence":"additional","affiliation":[{"name":"Department of Exercise Science, University of South Carolina, Columbia, South Carolina, USA"},{"name":"Center for Colon Cancer Research, University of South Carolina, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Baracos","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1200\/JCO.2012.48.3149","article-title":"Clinical trials of cancer cachexia therapy, now and hereafter","volume":"31","author":"Baracos","year":"2013","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Muscaritoli","year":"2008","journal-title":"Clin Nutr"},{"key":"6","first-page":"340","article-title":"Molecular pathways leading to cancer cachexia","volume":"20","author":"Tisdale","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"7","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ejca.2013.06.026","article-title":"Body composition and survival in the early clinical trials setting","volume":"49","author":"Kurzrock","year":"2013","journal-title":"Eur J Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Carson","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1742-7843.2010.00573.x","article-title":"Pre-clinical safety evaluation of pyrrolidine dithiocarbamate","volume":"107","author":"Doblhoff-Dier","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10","doi-asserted-by":"crossref","first-page":"31369","DOI":"10.1074\/jbc.M603762200","article-title":"Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytes","volume":"281","author":"Bernier","year":"2006","journal-title":"J Biol Chem"},{"key":"11","first-page":"209","article-title":"Antioxidant properties of pyrrolidine dithiocarbamate and its protection against Cr(VI)-induced DNA strand breakage","volume":"30","author":"Ding","year":"2000","journal-title":"Ann Clin Lab Sci"},{"key":"12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjp.0704463","article-title":"Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation","volume":"135","author":"Thiemermann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3171\/spi.2004.1.3.0311","article-title":"Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats","volume":"1","author":"Cuzzocrea","year":"2004","journal-title":"J Neurosurg Spine"},{"key":"14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.175.5.1181","article-title":"Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells","volume":"175","author":"Baeuerle","year":"1992","journal-title":"J Exp Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/jpet.111.185678","article-title":"Impact of pyrrolidine dithiocarbamate and interleukin-6 on mammalian target of rapamycin complex 1 regulation and global protein translation","volume":"339","author":"Bernier","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfg083","article-title":"Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells","volume":"73","author":"Mulcahy","year":"2003","journal-title":"Toxicol Sci"},{"key":"17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.expneurol.2005.11.021","article-title":"Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice","volume":"198","author":"Vita","year":"2006","journal-title":"Exp Neurol"},{"key":"18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/014860710703100118","article-title":"Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice","volume":"31","author":"Li","year":"2007","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130\u2032s role in Lewis lung carcinoma-induced cachexia","volume":"28","author":"Carson","year":"2014","journal-title":"FASEB J"},{"key":"20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1152\/japplphysiol.01270.2013","article-title":"Cachectic skeletal muscle response to a novel bout of low-frequency stimulation","volume":"116","author":"Carson","year":"2014","journal-title":"J Appl Physiol (1985)"},{"key":"21","article-title":"Lewis Lung Carcinoma Regulation of Mechanical Stretch-Induced Protein Synthesis in Cultured Myotubes","author":"Carson","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","article-title":"Interleukin 6 as a key regulator of muscle mass during cachexia","volume":"38","author":"Baltgalvis","year":"2010","journal-title":"Exerc Sport Sci Rev"},{"key":"23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Jacob","year":"1992","journal-title":"J Clin Invest"},{"key":"24","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Carson","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"25","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1152\/japplphysiol.00778.2005","article-title":"Myofiber degeneration\/regeneration is induced in the cachectic ApcMin\/+ mouse","volume":"99","author":"Carson","year":"2005","journal-title":"J Appl Physiol (1985)"},{"key":"26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1997.17","article-title":"Changes in nutritional status associated with unresectable pancreatic cancer","volume":"75","author":"Fearon","year":"1997","journal-title":"Br J Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"Carson","year":"2011","journal-title":"PLoS One"},{"key":"28","doi-asserted-by":"crossref","first-page":"e0119888","DOI":"10.1371\/journal.pone.0119888","article-title":"Liver inflammation and metabolic signaling in ApcMin\/+ mice: the role of cachexia progression","volume":"10","author":"Carson","year":"2015","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Zimmers","year":"2011","journal-title":"PLoS One"},{"key":"30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse","volume":"2","author":"Carson","year":"2012","journal-title":"Skelet Muscle"},{"key":"31","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1152\/ajpregu.00300.2010","article-title":"Muscle oxidative capacity during IL-6-dependent cancer cachexia","volume":"300","author":"Carson","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbadis.2014.12.015","article-title":"Sex differences in the relationship of IL-6 signaling to cancer cachexia progression","volume":"1852","author":"Carson","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"33","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1083\/jcb.201006098","article-title":"Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice","volume":"191","author":"Kumar","year":"2010","journal-title":"J Cell Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"DeChiara","year":"2001","journal-title":"Science"},{"key":"35","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Zimmers","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"36","article-title":"Eccentric Contraction-Induced Myofiber Growth in Tumor-Bearing Mice","volume":"2015","author":"Carson","year":"1985","journal-title":"J Appl Physiol"},{"key":"37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Shoelson","year":"2004","journal-title":"Cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Baldwin","year":"2000","journal-title":"Science"},{"key":"39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cyto.2006.05.001","article-title":"Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(\u2212\/\u2212) mouse","volume":"34","author":"Booth","year":"2006","journal-title":"Cytokine"},{"key":"40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1748-1716.2009.02029.x","article-title":"Overload-induced skeletal muscle extracellular matrix remodelling and myofibre growth in mice lacking IL-6","volume":"197","author":"Carson","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"41","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia","volume":"290","author":"Jackman","year":"2015","journal-title":"J Biol Chem"},{"key":"42","doi-asserted-by":"crossref","first-page":"e57141","DOI":"10.1371\/journal.pone.0057141","article-title":"Early activation of rat skeletal muscle IL-6\/STAT1\/STAT3 dependent gene expression in resistance exercise linked to hypertrophy","volume":"8","author":"Py","year":"2013","journal-title":"PLoS One"},{"key":"43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","article-title":"Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy","volume":"7","author":"Munoz-Canoves","year":"2008","journal-title":"Cell Metab"},{"key":"44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MCO.0000000000000164","article-title":"Muscle wasting in cancer: the role of mitochondria","volume":"18","author":"Busquets","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/emmm.201201869","article-title":"TSC22D4 is a molecular output of hepatic wasting metabolism","volume":"5","author":"Dallinga-Thie","year":"2013","journal-title":"EMBO Mol Med"},{"key":"46","doi-asserted-by":"crossref","first-page":"E409","DOI":"10.1152\/ajpendo.00453.2011","article-title":"Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats","volume":"302","author":"Liu","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","article-title":"The effect of exercise on IL-6-induced cachexia in the Apc (Min\/+) mouse","volume":"3","author":"Carson","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"48","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1096\/fj.10-168799","article-title":"Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique","volume":"25","author":"Hornberger","year":"2011","journal-title":"FASEB J"},{"key":"49","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","article-title":"Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min\/+) mouse","volume":"457","author":"Carson","year":"2009","journal-title":"Pflugers Arch"},{"key":"50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/1940-6207.CAPR-09-0017","article-title":"The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min\/+ mice","volume":"2","author":"Carson","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"51","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1152\/japplphysiol.00955.2007","article-title":"Effect of exercise on biological pathways in ApcMin\/+ mouse intestinal polyps","volume":"104","author":"Carson","year":"2008","journal-title":"J Appl Physiol (1985)"},{"key":"52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/toxsci\/kft104","article-title":"Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice","volume":"134","author":"Chatterjee","year":"2013","journal-title":"Toxicol Sci"},{"key":"53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2478\/raon-2014-0025","article-title":"The effect of radiation dose on mouse skeletal muscle remodeling","volume":"48","author":"Carson","year":"2014","journal-title":"Radiol Oncol"},{"key":"54","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.107.132290","article-title":"Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers","volume":"324","author":"Poelstra","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"55","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.nutres.2015.04.003","article-title":"Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model","volume":"35","author":"Murphy","year":"2015","journal-title":"Nutr Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:37:23Z","timestamp":1596713843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":55,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,9,13]]}},"alternative-id":["10699","27449092"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10699","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}